✨ Key Finding: Elevated lipoprotein(a) levels (≥47.26 mg/dL) nearly doubled the risk of 5-year major adverse cardiovascular events (HR 1.953, 95% CI 1.256–3.034, p=0.003) in Japanese STEMI patients.

“In Japanese patients with STEMI, elevated Lp(a) levels were independently associated with worse long-term outcomes. By Kensaku Nishihira https://t.co/p4jMUDtGsE #circ_j #CardioX https://t.co/k5QFtV3ej9”
✨ Key Finding: Invasive coronary angiography in 87.1% of NSTEMI patients was linked to 64% lower in-hospital mortality vs conservative management (weighted OR 0.36).
✨ Key Finding: Machine learning models predict postoperative atrial fibrillation after CABG with moderate accuracy (AUC 0.84, sensitivity 73%, specificity 83%) but face high heterogeneity.
Based on your interests and feeds
✨ Key Finding: The use of a wearable cardioverter-defibrillator resulted in a 1% delivery rate of appropriate shocks in patients with non-ischaemic cardiomyopathy, indicating a significant risk of life-threatening ventricular arrhythmias during the medical optimization period.
✨ Key Finding: Angio-FFR use during PCI showed similar 2-year MACE rates (24.8% vs 23.5%; HR 1.01) compared to pressure wire guidance in US Medicare patients.
✨ Key Finding: Advanced cardiac damage stages post-TAVI increase 12-month mortality: borderline HR 1.61, stage 3 HR 2.06, and stage 4 HR 2.77; stage 4 has highest CV mortality HR 3.13.
✨ Key Finding: Sarcomeric hypertrophic cardiomyopathy is linked to a worse prognosis, necessitating vigilant surveillance and lower thresholds for advanced therapies.
✨ Key Finding: A change from cardiac fibroblasts to cardiac myofibroblasts in the right ventricle is a driver of decompensation in pulmonary arterial hypertension.
✨ Key Finding: YAP induces a prorenewal metabolic state in cardiomyocytes, enhancing their potential for proliferation and heart regeneration.
✨ Key Finding: PRMT3-mediated arginine methylation stabilizes PCSK9, promoting aortic valve calcification in valve interstitial cells during calcific aortic valve disease.